Prof Clare Scott
Professor of Gynaecological Cancer
Department of Obstetrics, Gynaecology and Newborn Health
627 Scholarly works
5 Projects
HIGHLIGHTS
2024
Journal article
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
DOI: 10.1186/s12943-024-02048-12022
Research Contracts
Salary Contribution Ci Clare Scott 22/23
2020
Research Grant
A Multiple Modality Approach for Targeting Chemotherapy-and Parpi-Resisatnt Ovarian Cancer
2018
Journal article
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
DOI: 10.1038/s41467-018-05564-z2017
Journal article
Secondary somatic mutations restoring RAD51C and RAD51D associated with acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma
DOI: 10.1158/2159-8290.CD-17-04192017
Research Grant
Stics and Stones: A Randomised Phase Ii Double-Blind Placebo-Controlled Trial of Acetylsalicylic Acid (Asa) in Chemoprevention of Ovarian Cancer in Women With Brca1 and Brca2 Mutations
2016
Conference Proceedings
Secondary mutations in RAD51C and RAD51D are associated with acquired resistance to the PARP inhibitor rucaparib in patients with high-grade ovarian cancer
DOI: 10.1016/S0959-8049(16)32627-2
RECENT SCHOLARLY WORKS
2026
Journal article
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma
DOI: 10.1186/s13046-025-03629-82026
Journal article
Ovarian cancer
DOI: 10.1038/s41572-026-00686-x2026
Journal article
Uterine leiomyosarcoma: independent prognostic factors for overall and recurrence-free survival in a large international cohort
DOI: 10.1016/j.ijgc.2025.1031672026
Journal article
Long-Term Outcomes in Patients with Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors
DOI: 10.1001/jamaoncol.2026.19242026
Journal article
Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial
DOI: 10.1038/s41416-026-03535-62026
Journal article
Quality Matters: Linking Patterns of Care to Ovarian Cancer Survival in a National Gynae-Oncology Registry
DOI: 10.1200/OP-25-006642025
Journal article
EXPRESSION OF EMERGING THERAPEUTIC TARGET B7-H3 IN SARCOMA - A MASS SPECTROMETRY-BASED PROTEOMIC ANALYSIS OF >1000 SARCOMA SAMPLES
DOI: 10.1016/j.esmorc.2025.1000502025
Journal article
768P Operational challenges of molecular tumour board (MTBs) in the Australasian public healthcare services: A scoping survey to inform the future of precision oncology
DOI: 10.1016/j.annonc.2025.10.1183